Tenax Therapeutics, Inc. (TENX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 123.18M | 104.23M | 102.81M | 105.86M | 112.06M | 96.69M | 99.78M | 10.62M | 14.46M | 11.68M | 11.88M | 14.04M |
| Cash & Short-Term Investments | 118.75M | 97.56M | 99.37M | 105.46M | 111.45M | 94.85M | 98.31M | 9.38M | 12.55M | 9.79M | 11.14M | 13.39M |
| Cash Only | 118.75M | 97.56M | 99.37M | 105.46M | 111.45M | 94.85M | 98.31M | 9.38M | 12.55M | 9.79M | 11.14M | 13.39M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 4.42M | 6.66M | 3.44M | 395K | 88K | 64K | 33.88K | 50.25K | 66.63K | 251.58K | 267.08K | 282.58K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1.12K | 1.12K | 1.12K | 1.12K | 5.82K | 6.79K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.71K | 5.67K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1.12K | 1.12K | 1.12K | 1.12K | 1.12K | 1.12K |
| Total Assets | 123.18M | 104.23M | 102.81M | 105.86M | 112.06M | 96.69M | 99.78M | 10.62M | 14.46M | 11.68M | 11.89M | 14.05M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 9.92% | 7.8% | 3.03% | 897.06% | 674.94% | 727.46% | 739.31% | -24.41% | -5.31% | 243.19% | 150.87% | 68.1% |
| Total Current Liabilities | 8.49M | 7.16M | 6.6M | 2.53M | 2.77M | 4.69M | 2.56M | 1.74M | 2.03M | 3.59M | 602.21K | 823.84K |
| Accounts Payable | 6.35M | 6.04M | 5.61M | 562K | 1.84M | 3.16M | 1.58M | 869.66K | 1.08M | 2.07M | 134.79K | 206.46K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | 21.75K | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 278.8K | 413.17K | 500.9K | 174.47K | 345.75K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.14M | 1.11M | 991K | 1.97M | 332K | 1.34M | 871.72K | 160.58K | 282.93K | 236.88K | 47.42K | 41.63K |
| Current Ratio | 14.52x | 14.56x | 15.58x | 41.89x | 40.48x | 20.60x | 38.95x | 6.10x | 7.12x | 3.26x | 19.73x | 17.04x |
| Quick Ratio | 14.52x | 14.56x | 15.58x | 41.89x | 40.48x | 20.60x | 38.95x | 6.10x | 7.12x | 3.26x | 19.73x | 17.04x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 8.49M | 7.16M | 6.6M | 2.53M | 2.77M | 4.69M | 2.56M | 1.74M | 2.03M | 3.59M | 602.21K | 823.84K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 278.8K | 413.17K | 500.9K | 174.47K | 345.75K |
| Net Debt | -118.75M | -97.56M | -99.37M | -105.46M | -111.45M | -94.85M | -98.31M | -9.11M | -12.14M | -9.29M | -10.97M | -13.05M |
| Debt / Equity | - | - | - | - | - | - | - | 0.03x | 0.03x | 0.06x | 0.02x | 0.03x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | 0.08x | 0.28x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | -5.18x | -10.55x |
| Interest Coverage | - | - | - | - | - | - | -626.45x | -388.07x | -476.08x | -1496.49x | -368.49x | -120.23x |
| Total Equity | 114.69M | 97.07M | 96.21M | 103.33M | 109.29M | 91.99M | 97.22M | 8.88M | 12.43M | 8.1M | 11.29M | 13.22M |
| Equity Growth % | 4.94% | 5.52% | -1.04% | 1064.14% | 779.27% | 1035.98% | 761.4% | -32.87% | -12.94% | 442.5% | 185.46% | 94.9% |
| Book Value per Share | 2.54 | 2.48 | 2.42 | 2.61 | 2.99 | 6.02 | 4.59 | 4.53 | 10.20 | 32.59 | 37.84 | 47.83 |
| Total Shareholders' Equity | 114.69M | 97.07M | 96.21M | 103.33M | 109.29M | 91.99M | 97.22M | 8.88M | 12.43M | 8.1M | 11.29M | 13.22M |
| Common Stock | 2K | 1K | 1K | 0 | 0 | 0 | 341 | 196 | 196 | 30 | 2.39K | 2.39K |
| Retained Earnings | -383.17M | -367.45M | -351.91M | -336.11M | -325.26M | -314.86M | -308.59M | -304.63M | -301.05M | -297.25M | -294.03M | -292.06M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |